Miguel Izquierdo

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)”.

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

European Journal of Cancer(2021)10.1016/j.ejca.2021.01.053

N/A

0.685DataRank · unranked

28 citations

Eileen Holmes, Christian Jackisch, Evandro de Azambuja, Frances Boyle, David W. Hillman +37 more

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07159-9

N/A

0DataRank · unranked

2 citations

Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni +12 more

Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study

British Journal of Haematology(2024)10.1111/bjh.19316

N/A

0DataRank · unranked

6 citations

Junmin Li, Xiao Li, Depei Wu, Efreen Montaño Figueroa, Maria Guadalupe Rodriguez +15 more